Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2008
03/11/2008US7341552 Gene sets for glioma classification
03/11/2008US7340937 Method for determining hydrogen mobility as a function of temperature in superconducting niobium cavities
03/11/2008CA2600221A1 Measuring range extension of chromatographic rapid tests
03/11/2008CA2462280C Antibody complexes and methods for immunolabeling
03/11/2008CA2300358C Novel phytase
03/11/2008CA2289713C Immunoassay apparatus
03/11/2008CA2259307C Chromatographic assay or test device
03/08/2008CA2600772A1 Method for predicting biological, biochemical, biophysical, or pharmacological characteristics of a substance
03/07/2008WO2008078424A1 Benzoxazole derivatives
03/06/2008WO2008028162A2 Methods of screening agents for activity using teleosts
03/06/2008WO2008028116A2 Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test
03/06/2008WO2008028066A2 Boris isoforms and methods of detecting and treating disease
03/06/2008WO2008027942A2 Combination hepatitis c virus antigen and antibody detection method
03/06/2008WO2008027772A2 Ultrafast immunoextraction/displacement assays
03/06/2008WO2008027739A2 Antibodies to ntb-a
03/06/2008WO2008027717A1 Micro-laboratory
03/06/2008WO2008027624A1 Thermoplastic composition, coated conductor, and methods for making and testing the same
03/06/2008WO2008027459A2 Detecting a bacterial process in chronic rhinosinusitis
03/06/2008WO2008027411A1 System and method for trace gas leak detection of large leaks at relatively high test pressures
03/06/2008WO2008027379A2 Indicators of sirtuin activity and methods of use thereof
03/06/2008WO2008027098A2 Biosensor for measurement of species in a body fluid
03/06/2008WO2008027075A2 Sulfhydryl-reactive, water soluble dyes
03/06/2008WO2008027017A1 Modulation of neural activity and/or condition
03/06/2008WO2008026999A2 Candidates against infection
03/06/2008WO2008026906A1 Sperm capture assay using proteins zp2, zp3 and zp4
03/06/2008WO2008026741A1 Rapid diagnosis method specific to avian influenza virus
03/06/2008WO2008026584A1 METHOD FOR EVALUATING COMPOUND USING PKC-iota
03/06/2008WO2008026298A1 Remedy for kidney disease
03/06/2008WO2008026234A2 Method to identify and treat subjects resistant to acetyl salicylic acid
03/06/2008WO2008026205A1 Chemiluminescent method for identifying respiratory infections of different origins
03/06/2008WO2008026119A2 Microbe-sensitive indicators and use of the same
03/06/2008WO2008026102A2 Detection of hydrogen peroxide released by enzyme-catalyzed oxidation of an analyte
03/06/2008WO2008026095A1 Transmission-based optical detection systems
03/06/2008WO2008026010A1 Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer
03/06/2008WO2008026009A1 Protein
03/06/2008WO2008026008A1 Protein
03/06/2008WO2008025964A2 Antibodies to an epitope of agr2. assays and hybridomas
03/06/2008WO2008025877A1 Method and sampling kit for assessing the condition of the gastric mucosa
03/06/2008WO2008025579A1 Means and method for diagnosing hemolytic anemia
03/06/2008WO2008025564A2 Methods for detecting protein-peptide interactions
03/06/2008WO2008025558A2 Affinity marker comprising a first and a second tag and its use
03/06/2008WO2008025488A1 Plasmon resonance sensor
03/06/2008WO2008012362A3 New protein isoforms and uses thereof
03/06/2008WO2008010846A3 Methods for assessing protein-protein interactions using quantum dots and icpms
03/06/2008WO2008010837A9 Noncompetitive immunoassays to detect small molecules
03/06/2008WO2008009856A3 Modulators of hsd17b7 in the treatment of acne or of hyperseborrhoea
03/06/2008WO2008009748B1 Method for determining a characteristic parameter of a crp specimen
03/06/2008WO2008008298A3 Electrochemical test sensor
03/06/2008WO2008007291A3 Magnetic sensor device
03/06/2008WO2008005846A3 Methods, mixtures, kits and compositions pertaining to analyte determination
03/06/2008WO2008003312A3 Method and device for analyzing the adhesive behavior of platelets
03/06/2008WO2008002656A9 Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
03/06/2008WO2008001037A3 Methods for characterizing tissues
03/06/2008WO2008000512A3 Method for identifying crmp modulators
03/06/2008WO2007149476A3 Assays for non-apoptotic cell death and uses thereof
03/06/2008WO2007149270A9 Regulation of protein activity by reversible acetylation
03/06/2008WO2007149162A3 Independent measurement of dual sided properties of sheet material
03/06/2008WO2007147975A3 Antigenic surface structure of sperm cells associated with the y chromosome
03/06/2008WO2007147026A3 Ccr2 antagonists for chronic organ transplantation rejection
03/06/2008WO2007146883A3 Methods for assessing cancer susceptibility to carcinogens in tobacco products
03/06/2008WO2007143711A3 Blood-brain barrier targeting antibodies
03/06/2008WO2007142695A9 Methods and materials for the detection of leishmania infection
03/06/2008WO2007135483A3 Biomolecule interaction using atomic force microscope
03/06/2008WO2007135368A3 Dye compounds and the use of their labelled conjugates
03/06/2008WO2007134132A3 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
03/06/2008WO2007131778A3 Diagnostic and therapeutic uses of peptides for pre-forms of type 2 diabetes and conditions associated therewith
03/06/2008WO2007129277A3 A magnetic system
03/06/2008WO2007125479A3 Biosensor device
03/06/2008WO2007121184A9 Compounds and methods for diagnosis and treatment of leishmaniasis
03/06/2008WO2007120478A3 Glycomic patterns for the detection of disease
03/06/2008WO2007119179A3 Use of the ornithine transcarbamylase (otc), as a marker for diagnosing brain damages
03/06/2008WO2007114943A3 Methods and materials for controlling the electrochemistry of analyte sensors
03/06/2008WO2007112518A8 Live attenuated salmonella vaccine
03/06/2008WO2007105143A3 Sensor device with alternating excitation fields
03/06/2008WO2007105141A3 Magnetic sensor device with gain stabilization
03/06/2008WO2007100607A3 Immunogenic peptides and methods of use
03/06/2008WO2007097652A3 Synthetic mannosylglycerate derivatives for the stabilisation and preservation of biomaterials
03/06/2008WO2007093373A3 Branched multimeric peptides for tumor diagnosis and therapy
03/06/2008WO2007088502A3 Magnetic sensor device with reference unit
03/06/2008WO2007084163A3 Molecular characterization with carbon nanotube control
03/06/2008WO2007082057A3 Lectin arrays and translational applications
03/06/2008WO2007081804A3 Regulators of nfat
03/06/2008WO2007062101A3 Intraocular pressure-regulated early genes and uses thereof
03/06/2008WO2007047850A3 In situ assembly of protein microarrays
03/06/2008WO2007044932A3 Methods for indentification of inhibitors of enzyme activity
03/06/2008WO2007017663A8 Ultrasonic document inspection system
03/06/2008WO2005029040A8 System and methods for enhancing signal-to-noise ratios of microarray-based measurements
03/06/2008WO2001027311A3 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
03/06/2008US20080060100 Polypeptide Having 5 Fatty Acid Desaturating Activity, Polynucleotide Coding for the Polypeptide, and Use Thereof
03/06/2008US20080059077 Methods and systems of common motif and countermeasure discovery
03/06/2008US20080058667 Gas Monitoring System and Sidestream Gas Measurement System Adapted to Communicate with a Mainstream Gas Measurement System
03/06/2008US20080058631 Blood glucose meter having integral lancet device and test strip storage vial for single handed use and methods for using same
03/06/2008US20080058506 Labeling biopolymers with covalently binding reporter particles
03/06/2008US20080058505 Modified parathyroid hormone/peptides for use in prevention and treatment of bone disorders
03/06/2008US20080058433 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
03/06/2008US20080058431 Screening compounds to treat, stabilize, or prevent a higher than desired total body weight or a higher than desired percentage of body fat if the compound increases Shp2 activity by binding of Shp2 on the leptin receptor; Shp2 agonist; dietetics; eating disorders; glandular disorders
03/06/2008US20080058430 Method For Selecting Allosteric Regulators Of Class III G Protein-Coupled Receptors
03/06/2008US20080058429 Diagnosis Of Primary Open Angle Glaucoma
03/06/2008US20080058360 Soluble CD40L (CD 154) as a prognostic marker of atherosclerotic diseases
03/06/2008US20080058276 Cis, trans isomerization; serine, threonine profile; therapy, prevention neurodegenerative disorders